BDX - Becton Dickinson Biocorp team up for traceability of injectable drugs

• Becton, Dickinson and Company ( NYSE: BDX ) and French medical device maker Biocorp are collaborating on using connected technology to track adherence for self-administered drug therapies, like biologics.
• To improve adherence and outcomes of injectable drugs, the companies will integrate Biocorp's Injay technology – a solution to capture and transmit injection events using Near Field Communication (NFC) technology – to Becton, Dickinson's UltraSafe Plus Passive Needle Guard used with prefillable syringes.
• BDX on Tuesday said that Biocorp’s Injay is a cost-effective connected solution to monitor the use of pre-fillable syringes in clinical studies or routine care.
• Through NFC technology and sensors to identify the product, it can confirm a complete injection and transfer that information to a smartphone, the Franklin Lakes, N.J.-based healthcare equipment maker noted.

For further details see: